{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T03:07:41Z","timestamp":1770779261460,"version":"3.50.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>A number of studies have provided strong evidence for the use of cognitive behavior therapy (CBT) in the treatment of social anxiety disorder (SAD). However, all of the previous reports were from Europe and North America and it is unknown whether Western psychological therapies are effective for SAD in non-Western cultures. The present pilot study aimed to evaluate CBT program for SAD which was originally developed for Western patients, among Japanese patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Fifty-seven outpatients who participated in group CBT for SAD were evaluated using eight self-reported and one clinician-administered questionnaires to measure various aspects of SAD symptomatology at the beginning and at the end of the program. Pre- and post-treatment scores were compared and the magnitude of treatment effect was quantified as well based once on the intention-to-treat (ITT) and once among the completers only. We also examined baseline predictors of the CBT outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Seven patients (12%) did not complete the program. For the ITT sample, the percentage of reduction was 20% to 30% and the pre to post treatment effect sizes ranged from 0.37 to 1.01. Among the completers, the respective figures were 20% to 33% and 0.41 to 1.19. We found no significant pretreatment predictor of the outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Group CBT for SAD is acceptable and can bring about a similar degree of symptom reduction among Japanese patients with SAD as among Western patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-244x-7-69","type":"journal-article","created":{"date-parts":[[2007,12,11]],"date-time":"2007-12-11T07:13:56Z","timestamp":1197357236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Group cognitive behavior therapy for Japanese patients with social anxiety disorder: preliminary outcomes and their predictors"],"prefix":"10.1186","volume":"7","author":[{"given":"Junwen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Ietzugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshi A","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,10]]},"reference":[{"key":"256_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005, 62: 593-602. 10.1001\/archpsyc.62.6.593.","journal-title":"Arch Gen Psychiatry"},{"key":"256_CR2","first-page":"117","volume-title":"Social Anxiety Disorder","author":"S Seedat","year":"2004","unstructured":"Seedat S: Cross-Cultural Aspects of Social Anxiety Disorder. Social Anxiety Disorder. Edited by: Bandelow BSDJ. 2004, New York , Marcel Dekker, Inc., 117-130."},{"key":"256_CR3","first-page":"69","volume-title":"Social Phobia: Diagnosis, assessment and treatment","author":"DM Clark","year":"1995","unstructured":"Clark DM, Wells A: A cognitive model of social phobia. Social Phobia: Diagnosis, assessment and treatment. Edited by: Heimberg RG, Liebowitz M, Hope DA, Schneier FR. 1995, New York , Guilford Press, 69-93."},{"key":"256_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0005-7967(97)00022-3","volume":"35","author":"RM Rapee","year":"1997","unstructured":"Rapee RM, Heimberg RG: A cognitive-behavioral model of anxiety in social phobia. Behav Res Ther. 1997, 35: 741-756. 10.1016\/S0005-7967(97)00022-3.","journal-title":"Behav Res Ther"},{"key":"256_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/00004714-200106000-00011","volume":"21","author":"IC Fedoroff","year":"2001","unstructured":"Fedoroff IC, Taylor S: Psychological and pharmacological treatments of social phobia: a meta-analysis. J Clin Psychopharmacol. 2001, 21: 311-324. 10.1097\/00004714-200106000-00011.","journal-title":"J Clin Psychopharmacol"},{"key":"256_CR6","first-page":"291","volume":"4","author":"RA Gould","year":"1997","unstructured":"Gould RA, Buckminster S, Pollack MH, Otto MW, Massachusetts LY: Cognitive-behavioral and pharmacological treatment for social phobia: a meta-analysis. Clinical Psychology: Science and Practice. 1997, 4: 291-306.","journal-title":"Clinical Psychology: Science and Practice"},{"key":"256_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0005-7894(05)80040-1","volume":"26","author":"U Feske","year":"1995","unstructured":"Feske U, Chambless DL: Cognitive behavioral versus exposure only treatment for social phobia: a meta-analysis. Behavior Therapy. 1995, 26: 695-720. 10.1016\/S0005-7894(05)80040-1.","journal-title":"Behavior Therapy"},{"key":"256_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0005-7916(95)00058-5","volume":"27","author":"S Taylor","year":"1996","unstructured":"Taylor S: Meta-analysis of cognitive-behavioral treatments for social phobia. J Behav Ther Exp Psychiatry. 1996, 27: 1-9. 10.1016\/0005-7916(95)00058-5.","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"256_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.0.CO;2-5","volume":"10","author":"MR Liebowitz","year":"1999","unstructured":"Liebowitz MR, Heimberg RG, Schneier FR, Hope DA, Davies S, Holt CS, Goetz D, Juster HR, Lin SH, Bruch MA, Marshall RD, Klein DF: Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depress Anxiety. 1999, 10: 89-98. 10.1002\/(SICI)1520-6394(1999)10:3<89::AID-DA1>3.0.CO;2-5.","journal-title":"Depress Anxiety"},{"key":"256_CR10","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1037\/0022-006X.71.6.1058","volume":"71","author":"DM Clark","year":"2003","unstructured":"Clark DM, Ehlers A, McManus F, Hackmann A, Fennell M, Campbell H, Flower T, Davenport C, Louis B: Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psychol. 2003, 71: 1058-1067. 10.1037\/0022-006X.71.6.1058.","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"256_CR11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1037\/0022-006X.74.3.568","volume":"74","author":"DM Clark","year":"2006","unstructured":"Clark DM, Ehlers A, Hackmann A, McManus F, Fennell M, Grey N, Waddington L, Wild J: Cognitive therapy versus exposure and applied relaxation in social phobia: A randomized controlled trial. J Consult Clin Psychol. 2006, 74 (3): 568-78. 10.1037\/0022-006X.74.3.568.","journal-title":"J Consult Clin Psychol"},{"key":"256_CR12","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Edition","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. 1994, Washington, D.C. , American Psychiatric Association"},{"key":"256_CR13","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders","author":"MB First","year":"1997","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JB: Structured Clinical Interview for DSM-IV Axis I Disorders. 1997, Washington, D.C. , American Psychiatric Press"},{"key":"256_CR14","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9781316134948","volume-title":"The Treatment of Anxiety Disorders: Clinician Guides and Patient Manuals","author":"G Andrews","year":"2002","unstructured":"Andrews G, Creamer M, Crino R, Hunt C, Lampe L, Page A: The Treatment of Anxiety Disorders: Clinician Guides and Patient Manuals. 2002, Sydney , Cambridge University Press, 2nd","edition":"2nd"},{"key":"256_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/archpsyc.61.10.1005","volume":"61","author":"JR Davidson","year":"2004","unstructured":"Davidson JR, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM: Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry. 2004, 61: 1005-1013. 10.1001\/archpsyc.61.10.1005.","journal-title":"Arch Gen Psychiatry"},{"key":"256_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1192\/bjp.179.1.23","volume":"179","author":"S Blomhoff","year":"2001","unstructured":"Blomhoff S, Haug TT, Hellstrom K, Holme I, Humble M, Madsbu HP, Wold JE: Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry. 2001, 179: 23-30. 10.1192\/bjp.179.1.23.","journal-title":"Br J Psychiatry"},{"key":"256_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0005-7967(97)10031-6","volume":"36","author":"RP Mattick","year":"1998","unstructured":"Mattick RP, Clarke JC: Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther. 1998, 36: 455-470. 10.1016\/S0005-7967(97)10031-6.","journal-title":"Behav Res Ther"},{"key":"256_CR18","first-page":"841","volume":"44","author":"Y Kanai","year":"2004","unstructured":"Kanai Y, Sasakawa S, Chen J, Suzuki S, Shimada H, Sakano Y: Development and validation of the Japanese version of Social Phobia Scale and Social Interaction Anxiety Scale. Shingshin-Igaku (Jpn J Psychosom Med). 2004, 44: 841-850.","journal-title":"Shingshin-Igaku (Jpn J Psychosom Med)"},{"key":"256_CR19","volume-title":"Behavioural Psychotherapy: Maudsley Pocket Book of Clinical Management","author":"IM Marks","year":"1986","unstructured":"Marks IM: Behavioural Psychotherapy: Maudsley Pocket Book of Clinical Management. 1986, Bristol , IOP Publishing"},{"key":"256_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0005-7967(79)90041-X","volume":"17","author":"IM Marks","year":"1979","unstructured":"Marks IM, Mathews AM: Brief standard self-rating for phobic patients. Behav Res Ther. 1979, 17: 263-267. 10.1016\/0005-7967(79)90041-X.","journal-title":"Behav Res Ther"},{"key":"256_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1037\/h0027806","volume":"33","author":"D Watson","year":"1969","unstructured":"Watson D, Friend R: Measurement of social-evaluative anxiety. J Consult Clin Psychol. 1969, 33: 448-457. 10.1037\/h0027806.","journal-title":"J Consult Clin Psychol"},{"key":"256_CR22","first-page":"10","volume":"18","author":"R Ishikawa","year":"1992","unstructured":"Ishikawa R, Sasaki K, Fukui I: Standardization of Japanese version of FNE and SADS. Koudou Ryouhou Kenkyu (Jap J Behav Ther). 1992, 18: 10-17.","journal-title":"Koudou Ryouhou Kenkyu (Jap J Behav Ther)"},{"key":"256_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.janxdis.2004.02.003","volume":"19","author":"KA Collins","year":"2005","unstructured":"Collins KA, Westra HA, Dozois DJ, Stewart SH: The validity of the brief version of the Fear of Negative Evaluation Scale. J Anxiety Disord. 2005, 19: 345-359. 10.1016\/j.janxdis.2004.02.003.","journal-title":"J Anxiety Disord"},{"key":"256_CR24","first-page":"1077","volume":"44","author":"S Asakura","year":"2002","unstructured":"Asakura S, Inoue S, Sasaki F, Sasaki Y, Kitagawa N, Inoue T, Denda K, Ito M, Matsubara R, Koyama T: Reliability and Validity of the Japanese Version of the Liebowitz Social Anxiety Scale. Seishin Igaku (Clinical Psychiatry). 2002, 44: 1077-1084.","journal-title":"Seishin Igaku (Clinical Psychiatry)"},{"key":"256_CR25","first-page":"71","volume-title":"SCL-90-R: Administration, Scoring and Procedures Manual-II for the Revised Version and Other Instruments of the Psychopathology Rating Scale Series","author":"LR Derogatis","year":"1992","unstructured":"Derogatis LR: SCL-90-R: Administration, Scoring and Procedures Manual-II for the Revised Version and Other Instruments of the Psychopathology Rating Scale Series. 1992, Towson, MD , Clinical Psychometric Research, Inc., 71-"},{"key":"256_CR26","first-page":"233","volume":"25","author":"T Furukawa","year":"1996","unstructured":"Furukawa T, Nakanishi M, Sakurai A, Suzuki Y, Suzuki-Moore A, Hamanaka T: Effects of ethyl loflazepate in mood and neurosis-related disorders (ICD-10 JCM): Changes in SCL-90-R subscale scores. Rinsho Seishinigaku (Clinical Psychiatry). 1996, 25: 233-240.","journal-title":"Rinsho Seishinigaku (Clinical Psychiatry)"},{"key":"256_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1192\/bjp.180.5.461","volume":"180","author":"JC Mundt","year":"2002","unstructured":"Mundt JC, Marks IM, Shear MK, Greist JH: The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002, 180: 461-464. 10.1192\/bjp.180.5.461.","journal-title":"Br J Psychiatry"},{"key":"256_CR28","first-page":"101","volume-title":"Revised NEO Personality Inventory (NEO PI-R) and NEO Five-Factor Inventory (NEO-FFI): Professional Manual","author":"PT Costa","year":"1992","unstructured":"Costa PT, McCrae RR: Revised NEO Personality Inventory (NEO PI-R) and NEO Five-Factor Inventory (NEO-FFI): Professional Manual. 1992, Odessa, Florida , Psychological Assessment Resources, Inc., 101-"},{"key":"256_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2466\/pr0.2001.88.2.443","volume":"88","author":"K Yoshimura","year":"2001","unstructured":"Yoshimura K, Ono Y, Nakamura K, Nathan JH, Suzuki K: Validation of the Japanese version of the NEO Five-Factor Inventory in a large community sample. Psychol Rep. 2001, 88: 443-449. 10.2466\/PR0.88.2.443-449.","journal-title":"Psychol Rep"},{"issue":"9","key":"256_CR30","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.4088\/JCP.v67n0914","volume":"67","author":"B Bandelow","year":"2006","unstructured":"Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ: What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?. J Clin Psychiatry. 2006, 67 (9): 1428-1434.","journal-title":"J Clin Psychiatry"},{"key":"256_CR31","volume-title":"Statistical Power Analysis in the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J: Statistical Power Analysis in the Behavioral Sciences. 1988, Hillsdale, NJ , Erlbaum"},{"issue":"2","key":"256_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0887-6185(97)00004-2","volume":"11","author":"RA Kleinknecht","year":"1997","unstructured":"Kleinknecht RA, Dinnel DL, Kleinknecht EE, Hiruma N, Harada N: Cultural factors in social anxiety: a comparison of social phobia symptoms and Taijin Kyofusho. J Anxiety Disord. 1997, 11 (2): 157-177. 10.1016\/S0887-6185(97)00004-2.","journal-title":"J Anxiety Disord"},{"key":"256_CR33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0005-7967(02)00176-6","volume":"41","author":"U Stangier","year":"2003","unstructured":"Stangier U, Heidenreich T, Peitz M, Lauterbach W, Clark DM: Cognitive therapy for social phobia: individual versus group treatment. Behav Res Ther. 2003, 41: 991-1007. 10.1016\/S0005-7967(02)00176-6.","journal-title":"Behav Res Ther"},{"issue":"2","key":"256_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1600-0447.2006.00839.x","volume":"115","author":"E Mortberg","year":"2007","unstructured":"Mortberg E, Clark DM, Sundin O, Aberg Wistedt A: Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial. Acta Psychiatr Scand. 2007, 115 (2): 142-154. 10.1111\/j.1600-0447.2006.00839.x.","journal-title":"Acta Psychiatr Scand"},{"key":"256_CR35","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/archpsyc.55.12.1133","volume":"55","author":"RG Heimberg","year":"1998","unstructured":"Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF: Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch Gen Psychiatry. 1998, 55: 1133-1141. 10.1001\/archpsyc.55.12.1133.","journal-title":"Arch Gen Psychiatry"},{"key":"256_CR36","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cpr.2004.07.007","volume":"24","author":"TL Rodebaugh","year":"2004","unstructured":"Rodebaugh TL, Holaway RM, Heimberg RG: The treatment of social anxiety disorder. Clin Psychol Rev. 2004, 24: 883-908. 10.1016\/j.cpr.2004.07.007.","journal-title":"Clin Psychol Rev"},{"key":"256_CR37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0005-7967(98)00175-2","volume":"37","author":"A Scholing","year":"1999","unstructured":"Scholing A, Emmelkamp PM: Prediction of treatment outcome in social phobia: a cross-validation. Behav Res Ther. 1999, 37: 659-670. 10.1016\/S0005-7967(98)00175-2.","journal-title":"Behav Res Ther"},{"key":"256_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/j.1440-1614.2004.01345.x","volume":"38","author":"S Rosser","year":"2004","unstructured":"Rosser S, Erskine A, Crino R: Pre-existing antidepressants and the outcome of group cognitive behaviour therapy for social phobia. Aust N Z J Psychiatry. 2004, 38: 233-239. 10.1111\/j.1440-1614.2004.01345.x.","journal-title":"Aust N Z J Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-7-69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-7-69\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-7-69","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-7-69.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:25:54Z","timestamp":1630448754000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-7-69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["256"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-7-69","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"10 May 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"69"}}